Assignee

INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD

KY·24 granted patents·29 pending applications·11 citations·filing 2018–2025

Technology mixA61K53 C07K52 A61P44 C12N38 C12Y8 A61M2

Top patents by PatentIndex Score

53 records

0196US11104732B2Reducing immune inhibition induced by SIGLEC-15INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Aug 31, 2021·6 cites·22 claims
0285US11008556B2Chimeric antigen receptor (CAR) and T cell receptor (TCR) modified T cellsINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2018·Granted May 18, 2021·2 cites·17 claims
0384US11690874B2Use of chimeric antigen receptor modified cells to treat autoimmune diseaseINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Granted Jul 4, 2023·2 cites·11 claims
0482US2024218075A1Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
0581US2025188146A1Modified Cell Expansion and Uses ThereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
0679US12297267B2Humanized anti-CD19 antibody and use thereof with chimeric antigen receptorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Granted May 13, 2025·0 cites·16 claims
0778US11566223B2Chimeric antigen receptor cell preparation and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2018·Granted Jan 31, 2023·1 cites·21 claims
0876US11364289B2Humanized anti-CD19 antibody and use thereof with chimeric antigen receptorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Granted Jun 21, 2022·0 cites·12 claims
0976US2025025506A1Engineered safety in cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
1074US11932873B2Reducing immune tolerance induced by PD-L1INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Mar 19, 2024·0 cites·21 claims
1172US12150960B2Modified cell expansion and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Nov 26, 2024·0 cites·7 claims
1272US11970548B2Nanobody target GCC and uses in chimeric antigen receptor cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Granted Apr 30, 2024·0 cites·9 claims
1372US2025171560A1Chimeric antigen receptor cells for treating solid tumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
1471US11932700B2Use of chimeric antigen receptor modified cells to treat cancerINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Mar 19, 2024·0 cites·9 claims
1571US11834502B2Reducing immune inhibition induced by SIGLEC-15INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Dec 5, 2023·0 cites·19 claims
1670US12240915B2Chimeric antigen receptor cells for treating solid tumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Granted Mar 4, 2025·0 cites·19 claims
1770US2026055209A1Nanobody Target GCC and Uses in Chimeric Antigen Receptor Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
1869US11161913B2Chimeric antigen receptor cells for treating solid tumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Nov 2, 2021·0 cites·13 claims
1968US12076343B2Engineered safety in cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Sep 3, 2024·0 cites·20 claims
2068US11633427B2Vaccine and uses thereof in cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Granted Apr 25, 2023·0 cites·8 claims
2168US2023226113A1Vaccine and Uses thereof in Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
2268US2022339193A1Modified Cell Expressing Therapeutic Agent and Uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
2366US11701385B2Modulation of cell function for immunotherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Granted Jul 18, 2023·0 cites·14 claims
2465US2022000921A1Modified Cell Expressing Therapeutic Agent and Uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2019·Application pending·0 cites
2564US11773384B2Chimeric antigen receptor (CAR) and T cell receptor (TCR) modified T cellsINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Oct 3, 2023·0 cites·22 claims
2664US2024199760A1Nanobody Target MSLN and Uses in Chimeric Antigen Receptor Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
2763US2024058337A1Managing Side Effects in T Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
2863US2025121005A1CAR and Polyspecific Binding Molecules Targeting Solid TumorsINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
2962US11235004B2Lymphocyte cell lines and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2018·Granted Feb 1, 2022·0 cites·26 claims
3062US2026060984A1Recombinant Viral Particle for Gene and/or Cellular TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
3162US2021161961A1Modified Cell Expressing Therapeutic Agent and Uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
3261US2024075061A1Cell therapy activating lymphocyte in tmeINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
3361US2024299452A1Rapamycin and Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2024·Application pending·0 cites
3459US12043654B2Anti-GCC antibody and CAR thereof for treating digestive system cancerINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Jul 23, 2024·0 cites·21 claims
3559US11833174B2Modified cell with enhanced functionality and cellular therapy thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Dec 5, 2023·0 cites·17 claims
3659US11739136B2Inducible dominant negative PD-1 and uses in adoptive cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Aug 29, 2023·0 cites·11 claims
3759US2023227779A1Enhanced Chimeric Antigen Receptor Cells in Hypoxic Tumor MicroenvironmentINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2023·Application pending·0 cites
3858US11788072B2Activation of APC in immunotherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Oct 17, 2023·0 cites·18 claims
3957US11944645B2Modified cell and use thereof in gene and cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Granted Apr 2, 2024·0 cites·20 claims
4057US2024269182A1Modified Chimeric Antigen Receptor and Use thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
4156US2024307442A1Modified Cell Targeting Tumor ECM and Cellular Therapy thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
4255US11858977B2Modified TCR and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Granted Jan 2, 2024·0 cites·18 claims
4353US2023201258A1Polyspecific Binding Molecules and their use in Cell TherapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
4452US2023322899A1Fusion protein enhancing cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
4552US2021060069A1Coupled redirected cells and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites
4652US2024024476A1CAR Cells and Polyspecific Binding Molecules for Treating Solid TumorINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2022·Application pending·0 cites
4752US2021100841A1Presenting cell and use thereof in cell therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites
4852US2021137983A1Nk cell expansion and uses thereofINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites
4951US2023201440A1System and method for gene and/or cellular therapyINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2021·Application pending·0 cites
5050US2021024890A1Modulating t cell function and responseINNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD·Filed 2020·Application pending·0 cites

Showing the top 50 of 53 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →